|
C8ORF83 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.172400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.058600E-01 |
| Normal-vs-Stage2 |
3.193800E-01 |
| Normal-vs-Stage3 |
5.125400E-01 |
| Normal-vs-Stage4 |
3.226800E-01 |
| Stage1-vs-Stage2 |
6.734200E-01 |
| Stage1-vs-Stage3 |
9.068800E-01 |
| Stage1-vs-Stage4 |
3.386100E-02 |
| Stage2-vs-Stage3 |
6.678200E-01 |
| Stage2-vs-Stage4 |
1.418850E-01 |
| Stage3-vs-Stage4 |
1.996430E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.464230E-01 |
| Normal-vs-AfricanAmerican |
1.962370E-03 |
| Normal-vs-Asian |
6.538200E-01 |
| Caucasian-vs-AfricanAmerican |
1.52742999999234E-05 |
| Caucasian-vs-Asian |
6.048600E-01 |
| AfricanAmerican-vs-Asian |
3.228000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.413800E-01 |
| Normal-vs-Female |
2.113000E-01 |
| Male-vs-Female |
4.592800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.940000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.922600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.559400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.058200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.320600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.758200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.613800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.850200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.804990E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.081000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.239500E-02 |
| Normal-vs-Grade 2 |
1.212180E-02 |
| Normal-vs-Grade 3 |
7.967800E-01 |
| Normal-vs-Grade 4 |
2.698600E-03 |
| Grade 1-vs-Grade 2 |
7.783600E-01 |
| Grade 1-vs-Grade 3 |
5.537600E-02 |
| Grade 1-vs-Grade 4 |
7.616100E-04 |
| Grade 2-vs-Grade 3 |
4.159500E-03 |
| Grade 2-vs-Grade 4 |
1.03569999998498E-06 |
| Grade 3-vs-Grade 4 |
2.599100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.607100E-04 |
| Normal-vs-ccB subtype |
8.524000E-01 |
| ccA subtype-vs-ccB subtype |
3.401700E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.813560E-01 |
| Normal-vs-N1 |
2.701400E-01 |
| N0-vs-N1 |
1.274240E-01 |
|
|
